Form 4 for BBIO BridgeBio Pharma, Inc.
Accepted 2024-02-21 00:00:00 ET · period of report 2024-02-16 · accession 0000950170-24-017894 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2024-02-21 | 2024-02-16 | BBIO | HOMCY CHARLES J | Dir | F - Tax | $37.21 | -1,509 | 1.23M | -0.1% | -$56.1K |
| D | 2024-02-21 | 2024-02-16 | BBIO | HOMCY CHARLES J | Dir | M - OptEx | — | +3,760 | 1.23M | +0.3% | — |
| D | 2024-02-21 | 2024-02-16 | BBIO | HOMCY CHARLES J | Dir | M - OptEx | $0.00 | -3,760 | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-02-16 | F | D | 1,509 | $37.21 | 1,230,085 | D | — | — | (F3) Represents number of shares of the Issuer's Common Stock withheld to satisfy the Reporting Person's tax obligation in connection with the vesting of 3,760 shares of Common Stock underlying the Reporting Person's RSUs. |
| 2 | Common | Common Stock | 2024-02-16 | M | A | 3,760 | — | 1,231,594 | D | — | — | (F1) Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of the Issuer's Common Stock. (F2) Includes 838 shares of the Issuer's Common Stock acquired by the Reporting Person on February 15, 2024 pursuant to the Issuer's Employee Stock Purchase Plan in a transaction exempt under Rule 16b-3. |
| 3 | Derivative | Restricted Stock Units | 2024-02-16 | M | D | 3,760 | $0.00 | 0 | D | — · — to — | 3,760 Common Stock | (F1) Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of the Issuer's Common Stock. (F4) The RSUs vested with respect to 1/8th of the underlying shares on May 16, 2022; thereafter, 1/8th of the underlying shares vested on a quarterly basis, subject to the Reporting Person's continued service with the Issuer or any of its subsidiaries through each vesting date. The RSUs have no expiration date. |